I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Postural tachycardia syndrome (POTS) patients show symptoms of orthostatic intolerance with increasing heart rate (HR) when the body moves from supine to an upright position or after standing for a long period.\[[@ref1]\] Our group reported that POTS was present in 6.9% of children.\[[@ref2]\] The pathogenesis of POTS, however, is unclear. Previous studies have shown that decreases in blood volume, endothelial dysfunction, increased adrenergic response, small fiber neuropathy, autonomic nervous system imbalance, and muscle pump dysfunction may be involved in its pathogenesis.\[[@ref3]\] Regardless, the current vascular mechanisms underlying POTS remain unclear.

Sulfur dioxide (SO~2~), a gaseous molecule, has recently been found to have physiological and pathophysiological properties in the cardiovascular system and has attracted a great attention in the recent years.\[[@ref4][@ref5][@ref6][@ref7][@ref8]\] It was shown that endogenous and exogenous SO~2~ have vasodilatory effects.\[[@ref5][@ref6][@ref7][@ref8]\] Zhao *et al*.\[[@ref9]\] found spontaneous blood pressure decrease in hypertensive rats when SO~2~ donor was applied, which suggested that SO~2~ played an important role in the regulation of vascular function. However, changes in plasma SO~2~ levels in children with POTS and their significance have not yet been analyzed. The present study was designed to explore the plasma SO~2~ content in POTS children and its relationship with hemodynamic parameters in addition to symptom scoring, thus revealing its possible involvement of SO~2~ in the pathogenesis of POTS.

M[ETHODS]{.smallcaps} {#sec1-2}
=====================

Selection and description of participants {#sec2-1}
-----------------------------------------

The study included 31 POTS children (11 boys and 20 girls) from Peking University First Hospital between December 2013 and October 2015. The mean age range of patients was 12.3 ± 2.3 years. The POTS group had substantial symptoms, such as vertigo, dizziness, headaches, palpitations, chest tightness, changes in complexion, fatigue, blurred vision, and early morning discomfort. The supine position could effectively relieve symptoms, and all patients had a positive head-up test and no other cardiovascular diseases.\[[@ref10][@ref11][@ref12]\] The controls included 27 children (11 boys and 16 girls) with a mean age of 12.0 ± 0.8 years. They were healthy children without syncope, chest tightness, headache, or other symptoms of orthostatic intolerance, as demonstrated by a normal medical history, physical examination, and laboratory findings. All controls had a negative head-up test and no other cardiovascular diseases. All participants had no recent infection history and no consumption of caffeine, fat, or Vitamin C.

Ethical approval {#sec2-2}
----------------

Guardians of all children were informed of the study purpose and research methods, and informed consent was obtained from all individual participants included in the study. The study was approved by the First Hospital of Peking University Ethics Committee in Beijing. The procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the *Helsinki declaration* of 1975, as revised in 2000.

Technical information {#sec2-3}
---------------------

**Head-up tilt test**

Head-up tilt test was applied to diagnose POTS. First, children were kept quietly in the supine position on the tilt table (HUT-821, Beijing Juchi, China) for 10 min, and their HR, blood pressure, and electrocardiograph were recorded by a Dash 2000 Multi-lead Physiological Monitor (General Electric, New York, USA). Then, the tilt table was tilted to 60° angle, and the HR, blood pressure, and an electrocardiograph were monitored until the occurrence of a positive response or the completion of the test (with a process of 45 min). During the test, if the HR increased by ≥40 beats or the maximum HR of ≥130 times/min (6--12 years) or ≥125 beats/min (13--18 years) was accompanied by two of the following symptoms such as dizziness or vertigo, headache, fatigue, blurred vision, morning discomfort, palpation, chest tightness, and paleness, the positive of POTS could be diagnosed.\[[@ref11][@ref12]\]

**Symptom score calculation**

To avoid the influence of different operators, all the symptoms were assessed by one operator. The symptom scores included the following ten symptoms: distraction, nausea, palpitations, headache, tremor, syncope, dizziness or vertigo, lightheadedness, sweating, and blurred vision, and the final score was calculated by summing the scores of separate symptoms. Zero point was given if the symptom did not occur; 1 point was given if the symptom occurred once per month; 2 points were given if the symptom occurred 2--4 times/month; 3 points were given if the symptom occurred 2--7 times/week; and 4 points were given if the symptom occurred more than once per day.\[[@ref13][@ref14][@ref15]\]

**Plasma sulfur dioxide measurement**

SO~2~ concentrations were determined as follows.\[[@ref8]\] When children were kept in the supine position, blood was obtained and placed in an anticoagulant tube and was then centrifuged at 2000 rpm for 20 min. Then, aprotinin (Kangjia Hongyuan, China) at a ratio of 1:100 was added to the supernatant. The supernatant was stored in a refrigerator at −20°C. For high-performance liquid chromatography analysis of SO~2~, 100 μl of plasma, 70 μl of sodium borohydride (Sigma Company, USA), and 10 μl of mBrB (Sigma Company, USA) were added to a tube, which were then incubated at 42°C for 7 min. Then, 50 μl of a perchloric acid mixture was added before the plasma was centrifuged at 12,400 rpm for 10 min. The two mobile phases used for analysis consisted of methanol (JT Baker Company, USA): acetic acid (Guoyao Company, China): water at a volume ratio of 5:0.25:94.75, potential of hydrogen 3.4, and pure methanol. All detection procedures were performed at an excitation wavelength of 390 nm and absorption wavelength of 479 nm. The human subjects\' samples were collected from December 2013 to October 2015. We had access to information that could identify individual participants during or after data collection.

Statistical analysis {#sec2-4}
--------------------

Data were analyzed using SPSS 20.0 (SPSS, Chicago, IL, USA). The homogeneity of variance was analyzed by the Kolmogorov--Smirnov *Z*-test. Differences between the two groups were compared using a *t*-test. The sex ratio was analyzed using the Chi-square test. Correlations were analyzed using the Pearson\'s correlation. A value of *P* \< 0.05 was considered statistically significant. The predictive value of plasma SO~2~ was determined using a receiver operating characteristic curve. If the confidence interval (*CI*) for AUC had a value of *P* \< 0.05, the indicator was considered to have predictive value.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

Demographic data, hemodynamics, and plasma sulfur dioxide {#sec2-5}
---------------------------------------------------------

The maximum HR was faster and the baseline plasma SO~2~ level was higher in the POTS group than that in the control group (*P* \< 0.05). No significant differences in age, weight, and systolic and diastolic blood pressures during the supine posture and the standing posture were found between the POTS group and the control group (*P* \> 0.05) \[[Table 1](#T1){ref-type="table"}\].

###### 

Demographic characteristics, hemodynamics, and plasma SO~2~

  Items                         Control (*n* = 27)   POTS (*n* = 31)   *t*/*χ*^2^   *P*
  ----------------------------- -------------------- ----------------- ------------ --------
  Gender (male/female)          11/16                11/20             0.169        \>0.05
  Age (years)                   12.0 ± 0.8           12.3 ± 2.3        0.702        \>0.05
  Height (cm)                   145.3 ± 10.4         157.9 ± 15.8      3.551        \<0.01
  Weight (kg)                   42.4 ± 7.32          48.8 ± 15.4       1.973        \>0.05
  Supine SBP (mmHg)             107.1 ± 10.0         109.2 ± 15.8      0.618        \>0.05
  Supine DBP (mmHg)             67.3 ± 7.9           65.7 ± 11.6       −0.597       \>0.05
  Supine HR (bpm)               83.9 ± 7.3           76.8 ± 10.0       −3.052       \<0.01
  HR~max~ (bpm)                 104.2 ± 7.1          124.2 ± 10.3      8.473        \<0.01
  Upright SBP (mmHg)            112.1 ± 10.0         106.2 ± 15.6      −1.679       \>0.05
  Upright DBP (mmHg)            73.0 ± 8.4           71.0 ± 11.1       −0.789       \>0.05
  Basal plasma SO~2~ (µmol/L)   27.2 ± 9.6           64.0 ± 20.8       8.439        \<0.01

All data were shown as mean ± SD or *n*. POTS: Postural tachycardia syndrome; SBP: Systolic pressure; DBP: Diastolic blood pressure; HR: Heart rate; HR~max~: Maximum heart rate; SO~2~: Sulfur dioxide.

The receiver operating characteristic curve of plasma sulfur dioxide for predicting the diagnosis of postural tachycardia syndrome {#sec2-6}
----------------------------------------------------------------------------------------------------------------------------------

The AUC was 96.7% (95% *CI*, 0.928--1.000), indicating that it yielded a high predictive value for using a plasma SO~2~ cutoff value of 38.17 μmol/L to support the diagnosis of POTS. The sensitivity was 90.3% and the specificity was 92.6% \[[Figure 1](#F1){ref-type="fig"}\].

![The ROC curve of the plasma SO~2~ level for the diagnosis of POTS. The longitudinal axis represents the sensitivity in the diagnosis of POTS. The transverse axis represents the false-positive rate (1-specificity) of the diagnosis. The area under the curve was 96.7% (95% confidence interval: 0.928--1.000; *P* \< 0.01). ROC: Receiver operating characteristic; SO~2~: Sulfur dioxide; POTS: Postural tachycardia syndrome.](CMJ-131-435-g001){#F1}

Correlation between symptom scores and plasma sulfur dioxide levels {#sec2-7}
-------------------------------------------------------------------

The symptom scores were positively correlated with plasma SO~2~ levels in the POTS group (*n* = 31, *r* = 0.398, *P* \< 0.05) \[[Figure 2a](#F2){ref-type="fig"}\].

![Correlation analysis between symptom scores and plasma SO~2~ levels and between maximum HR and plasma SO~2~ levels in patients. (a) Correlation analysis between symptom scores and plasma SO~2~ levels in children with POTS. Symptom scores and plasma SO~2~ levels were positively correlated in the POTS group (*n* = 31, *r* = 0.398, *P* \< 0.05). (b) Correlation analysis of the maximum HR and plasma SO~2~ levels. In all the study participants, the maximum HR was positively correlated with the plasma SO~2~ level (*n* = 58, *r* = 0.679, *P* \< 0.01). SO~2~: Sulfur dioxide; POTS: Postural tachycardia syndrome; HR: Heart rate.](CMJ-131-435-g002){#F2}

Correlation between the maximum heart rate and plasma sulfur dioxide levels in children {#sec2-8}
---------------------------------------------------------------------------------------

In all the study participants, the maximum HR was positively correlated with plasma SO~2~ level (*n* = 58, *r* = 0.679, *P* \< 0.01) \[[Figure 2b](#F2){ref-type="fig"}\].

Change in systolic blood pressure from a supine to an upright position in the postural tachycardia syndrome group and controls {#sec2-9}
------------------------------------------------------------------------------------------------------------------------------

The upright systolic blood pressure (SBP) was significantly increased relative to the supine SBP in controls. However, the upright SBP exhibited a decreasing trend compared to the supine SBP in the POTS group. The SBP change from a supine to an upright position (ΔSBP) significantly differed between the two groups (*P* \< 0.01) \[[Figure 3a](#F3){ref-type="fig"}\].

![Blood pressure and plasma SO~2~ analysis. (a) Comparison of the ΔSBP between the POTS and control groups. The difference in the ΔSBP between the two groups was statistically significant (*P* \< 0.01). (b) The correlation between ΔSBP and plasma SO~2~ in all participants (*n* = 58, *r* = −0.28, *P* \< 0.05). (c) Correlation analysis of ΔSBP and plasma SO~2~ levels in the control group (*n* = 27, *r* = 0.487, *P* \< 0.01). SO~2~: Sulfur dioxide; POTS: Postural tachycardia syndrome; ΔSBP: Systolic blood pressure from the supine to upright.](CMJ-131-435-g003){#F3}

Correlation between the change in systolic blood pressure from supine to an upright position and baseline plasma sulfur dioxide levels in participants {#sec2-10}
------------------------------------------------------------------------------------------------------------------------------------------------------

The ΔSBP was positively correlated with baseline plasma SO~2~ levels in all participants (*n* = 58, *r* = −0.28, *P* \< 0.05) \[[Figure 3b](#F3){ref-type="fig"}\]. The ΔSBP was positively correlated with baseline plasma SO~2~ levels in the control group (*n* = 27, *r* = 0.487, *P* \< 0.01) \[[Figure 3c](#F3){ref-type="fig"}\]. The SBP had no correlation with baseline plasma SO~2~ levels in the POTS group (*n* = 31, *P* \> 0.05).

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

Currently, the pathogenesis of POTS is not fully understood, although abnormal diastolic function and endothelial function in POTS children were proposed and confirmed. In 1940, MacLean and Allen first reported the presence of hypovolemia in children with POTS, and further studies revealed an increased venous capacity in the lower extremities of children with POTS attributable to the local anatomy and functional abnormality of the lower limbs.\[[@ref16][@ref17]\] The decrease in 24-h urinary sodium excretion might be related to changes in circulation volume in POTS children.\[[@ref18][@ref19]\] Although significant progress has been made in the study of the pathogenesis of POTS concerning the cause of abnormal vasodilation and vascular endothelial dysfunction, uncertainty still remains, which requires further study.

In the recent years, an endogenous SO~2~ pathway was discovered in the cardiovascular system,\[[@ref20]\] and SO~2~ could cause vasodilation and regulate endothelial cell function.\[[@ref5][@ref6][@ref7]\] Our team observed that an SO~2~ donor, sodium sulfite/sodium bisulfite, could lead to a significant decrease in blood pressure,\[[@ref8]\] and the application of an SO~2~ donor resulted in a significant relaxation of the aortic rings.\[[@ref21]\] Therefore, to explore the possible mechanisms responsible for the development of POTS, in this present study, we first showed that the plasma concentration of SO~2~ in POTS group (64.0 ± 20.8 μmol/L) was significantly higher than that of the control group (27.2 ± 9.6 μmol/L) \[[Table 1](#T1){ref-type="table"}\]. More interestingly, there was a significant decrease in blood pressure when patients changed their posture from supine to upright as compared with the controls. Hence, the possible reason for this increase in HR is likely associated with the decrease of blood pressure from the supine to upright position in POTS since patients with POTS need to have an excessively increased HR to compensate for the possibly reduced cardiac output caused by the decreased blood pressure. Therefore, the increased plasma SO~2~ may be responsible for the decrease in blood pressure in POTS children, which was likely involved in the pathogenesis of POTS. Furthermore, our findings that the plasma SO~2~ level was positively correlated with the maximum HR during upright posture and the symptom scores of the patients further confirmed our abovementioned hypothesis that endogenous SO~2~ was involved in the pathogenesis of POTS.

As for the mechanisms for SO~2~ vasorelaxation, people found that the vasodilatory effects of SO~2~ were blocked by nicardipine, a calcium channel blocker, and glyburide, a K~ATP~ channel blocker,\[[@ref22][@ref23][@ref24][@ref25]\] which suggests an involvement of calcium channels and K~ATP~ channel in vasorelaxation. The vasodilatory mechanism of SO~2~ depends on its concentration. If the concentration of SO~2~ is \>500 μmol/l, the vasodilatory effects are independent of the endothelial system but related to K~ATP~ channels and the inhibition of L-type calcium channels.\[[@ref22][@ref23][@ref24]\] In contrast, if the concentration of SO~2~ is \<450 μmol/L, the vasorelaxant mechanism depends on the big-conductance calcium-activated K^+^ (BKCa) and cyclic guanosine monophosphate.\[[@ref24]\] SO~2~ induced the K~ATP~ and BKCa channel activation via upregulating the expressions of Kir6.1, Kir6.2, SUR2B, and BKCa channel subunits α and β1 in rat aortic rings, while SO~2~ inhibited the L-type calcium channel by downregulating the Cav1.2 and Cav1.3 expressions.\[[@ref25]\]

A significant difference in body height is observed in POTS children, which would result in a different body mass index in children with POTS. Previous studies have shown that children with POTS might have a lower body mass index than the control group,\[[@ref26]\] although the body mass index had no correlation with the plasma content of SO~2~ in children with POTS (*P* = 0.471) in the present study.

The current study has several limitations. The findings showed that endogenous SO~2~ was involved in the pathogenesis of POTS. However, the study could not show a causal relationship between SO~2~ and the pathogenesis of POTS. Air pollution is prevalent, and SO~2~ exposure could affect the overall health of the population. Previous studies have found that a 10-μg/m^3^ increase in SO~2~ was associated with emergency treatments with odds ratios of 1.026 (95% *CI*: 1.019--1.033) for circulatory diseases and 1.037 (95% *CI*: 1.020--1.055) for coronary heart disease.\[[@ref27]\] However, the effect of SO~2~ in the air on POTS requires further study. Cohort studies for both controls and patients from rural areas and studies of POTS according to ethnicity would be useful for future investigations. In addition, in future studies, a large sample size with long-term follow-up is needed to clarify the role of SO~2~ in the pathogenesis of POTS, especially regarding the vascular mechanisms for functional cardiovascular diseases.
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